Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.

Trial Profile

Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Dec 2015

At a glance

  • Drugs Diquafosol (Primary) ; Hyaluronic acid (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Dec 2015 Status changed from active, no longer recruiting to completed as per results published in the American Journal of opthalmology
    • 11 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top